KeyBank National Association
BMY.RT

KeyBank National Association’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

KeyBank National Association’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-59,276
Closed -$41K – 1086
2020
Q4 		$41K Sell
59,276
-7,656
-11% -$16.3K ﹤0.01% 1031
2020
Q3 		$151K Sell
66,932
-3,026
-4% -$8.64K ﹤0.01% 961
2020
Q2 		$250K Sell
69,958
-13,982
-17% -$50.4K ﹤0.01% 849
2020
Q1 		$319K Sell
83,940
-89,567
-52% -$295K ﹤0.01% 748
2019
Q4 		$522K Buy
+173,507
New +$451K ﹤0.01% 714

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

KeyBank National Association's BMY.RT Position: Q1 2021 in Review

KeyBank National Association sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 59,276 shares — an estimated $41K sold.

KeyBank National Association first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $522K in Q4 2019. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • KeyBank National Association reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • KeyBank National Association sold 59,276 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $41K.
  • KeyBank National Association first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • KeyBank National Association's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $522K in Q4 2019.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on KeyBank National Association's 13F filing for Q1 2021, filed 7 May 2021.